MUNDELEIN, IL--(MARKET WIRE)--Aug 18, 2008 -- Medline Industries, Inc. announced today a new prevention campaign targeting six hospital-acquired conditions (HACs) and the creation of a $1 million research grant program to support the adoption of evidence-based solutions in healthcare institutions at its Prevention Above All forum in Chicago.

Source: Medline Industries
Medline's Prevention Above All program provides evidenced-based solutions for six hospital-acquired conditions.

More than 80 chief nursing officers, chief medical officers and healthcare quality executives from across the U.S. are attending the two day forum, where healthcare policy experts and professionals are providing guidance on changes to the Centers for Medicare & Medicaid Services (CMS) reimbursement policy for HACs and targeted interventions available. Starting October 1, CMS will pay healthcare providers a lower-weighted diagnosis-related group for certain HACs when those conditions could have been reasonably prevented by following evidence-based guidelines.

"There are some very innovative and proven solutions available to prevent hospital-acquired conditions," said Medline president Andy Mills. "Our goal with the Prevention Above All campaign is to help healthcare providers understand the benefits of these solutions and provide the evidence they need to be assured that they offer both clinical and cost-effectiveness."

While there has been much industry discussion on the issue of HACs, very little has centered on the proven solutions available or the challenges of implementation. In addition to providing clarity to the complex issues associated with the CMS policy change, the Prevention Above All campaign also targets a broader issue in healthcare today -- the need to utilize new technologies and better approaches to improve patient care.

"Implementing innovative solutions is a major challenge for healthcare providers -- many are typically slow adopters when it comes to trying new equipment or different ways of working," said Mills. "Providing targeted interventions that translate research findings into practice will allow healthcare providers to try new technologies with confidence."

Medline also aims to stimulate the gathering of solid evidence that supports the adoption of solutions into clinical practice by committing up to $1 million in total costs over several years to fund new grants focused on the HACs CMS has targeted. An independent review panel, whose members represent a breadth of research and practice knowledge, will select grant recipients to be awarded up to $25,000 each for pilot grants or $100,000 each for an empirical study. The first grants will be awarded and funded in 2009 and will cover several areas: pressure ulcers, hand hygiene compliance, retained surgical objects, catheter-associated urinary tract infections, surgical site infections and other pertinent safety and quality areas. The initial request for proposals is expected to be announced in November.

The program will be chaired by Andrew Kramer, M.D., Head of the Department of Medicine's Health Care Policy and Research Division at the University of Colorado and a frequent advisor to the CMS.

About Medline

Medline, the nation's largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended care facilities, surgery centers, home care dealers and agencies and other markets. Headquartered in Mundelein, IL, Medline has more than 800 dedicated sales representatives nationwide to support its broad product line and cost management services.

Meeting the highest level of national and international quality standards, Medline is FDA QSR compliant and ISO 13485 registered. Medline serves on major industry quality committees to develop guidelines and standards for medical product use, including the FDA Midwest Steering Committee, AAMI Sterilization and Packaging Committee, and various ASTM committees. For more information on Medline, visit our website, www.medline.com.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=818855

     Media Contact:
     Jerreau Beaudoin
     Office: 847-643-3011
     Mobile: 224-213-9878